Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 2, Pages 294
Publisher
MDPI AG
Online
2022-01-10
DOI
10.3390/cancers14020294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
- (2021) Moran Yang et al. Journal for ImmunoTherapy of Cancer
- Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
- (2021) Yongchao Li et al. Frontiers in Oncology
- Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
- (2021) Kevin Litchfield et al. CELL
- Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
- (2021) Na Li et al. Frontiers in Genetics
- CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
- (2021) Xuezhi Zhou et al. Frontiers in Oncology
- CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer
- (2021) Mathieu Rouanne et al. EUROPEAN JOURNAL OF CANCER
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
- (2021) Ayse Bassez et al. NATURE MEDICINE
- Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
- (2021) Chia-Lang Hsu et al. Liver Cancer
- Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
- (2021) Yufei Lv et al. Frontiers in Genetics
- The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13
- (2021) Costanza Zanetti et al. BLOOD
- CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer
- (2021) Xingyu Chen et al. ONCOGENE
- Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts
- (2021) Anthony B. Rodriguez et al. Cell Reports
- CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
- (2021) Kerstin Wennhold et al. Cancer Immunology Research
- Global Pattern of CD8+ T-Cell Infiltration and Exhaustion in Colorectal Cancer Predicts Cancer Immunotherapy Response
- (2021) Sun Tian et al. Frontiers in Pharmacology
- Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice
- (2021) Francesca R. Delvecchio et al. Cellular and Molecular Gastroenterology and Hepatology
- Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma
- (2021) Shi-yi Wu et al. BMC GASTROENTEROLOGY
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
- (2021) Yuanyuan Zhang et al. CANCER CELL
- Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
- (2021) Meng Qin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer
- (2021) Caroline A. Nebhan et al. JAMA Oncology
- 360 Tumor-immune signatures associated with response or resistance to tislelizumab in patients with previously treated advanced hepatocellular carcinoma (HCC)
- (2021) Chiun Hsu et al. Journal for ImmunoTherapy of Cancer
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- TNF-α and IL-10 Control CXCL13 Expression in Human Macrophages
- (2020) Nessrine Bellamri et al. JOURNAL OF IMMUNOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention
- (2020) Camille Jacqueline et al. SEMINARS IN IMMUNOLOGY
- Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies
- (2020) Camille-Charlotte Balança et al. Cancer Immunology Research
- Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic
- (2020) Alex Friedlaender et al. Frontiers in Oncology
- Cancer cell CCR2 orchestrates suppression of the adaptive immune response
- (2020) Miriam R. Fein et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits
- (2020) Jinyong Choi et al. NATURE IMMUNOLOGY
- ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC
- (2020) Sangeeta Goswami et al. Science Translational Medicine
- Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
- (2020) Manuela Terranova-Barberio et al. Nature Communications
- TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
- (2020) Longbin Guo et al. Cancer Medicine
- PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
- (2020) Camille-Charlotte Balança et al. JCI Insight
- CXCL13/CXCR5 Axis Predicts Poor Prognosis and Promotes Progression Through PI3K/AKT/mTOR Pathway in Clear Cell Renal Cell Carcinoma
- (2019) Zaosong Zheng et al. Frontiers in Oncology
- A transcriptionally distinct CXCL13+CD103+CD8+ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer
- (2019) Hagma H Workel et al. Cancer Immunology Research
- Type I interferon induces CXCL13 to support ectopic germinal center formation
- (2019) Alice E. Denton et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypoxia‐inducible factor‐1α and nuclear factor‐κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non‐small‐cell lung cancer cells
- (2019) Rong Guo et al. CANCER SCIENCE
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Cutting Edge: Tcf1 Instructs T Follicular Helper Cell Differentiation by Repressing Blimp1 in Response to Acute Viral Infection
- (2019) Peng Shao et al. JOURNAL OF IMMUNOLOGY
- The role of CXCL13 and CXCL9 in early breast cancer
- (2019) Evangelia Razis et al. Clinical Breast Cancer
- Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis
- (2019) Tianbo Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
- (2019) Imran G. House et al. CLINICAL CANCER RESEARCH
- CXCL13-mediated recruitment of intrahepatic CXCR5+CD8+ T cells favors viral control in chronic HBV infection
- (2019) Yongyin Li et al. JOURNAL OF HEPATOLOGY
- Editorial: The Role of Chemoattractants in the Tumor Microenvironment
- (2019) Giovanni Bernardini et al. Frontiers in Immunology
- CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
- (2019) Guolin Zhang et al. Cancer Research and Treatment
- Chemokines in homeostasis and diseases
- (2018) Keqiang Chen et al. Cellular & Molecular Immunology
- A guide to chemokines and their receptors
- (2018) Catherine E. Hughes et al. FEBS Journal
- A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
- (2018) Daniela S. Thommen et al. NATURE MEDICINE
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- LPS promotes the expression of PD-L1 in gastric cancer cells through NF-κB activation
- (2018) Hui Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells
- (2018) Silvia Caggia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments
- (2018) Hiroyuki Yoshitomi et al. Nature Communications
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
- (2018) Cheng Xu et al. BMJ-British Medical Journal
- Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway
- (2017) Zhanshan Cha et al. EXPERIMENTAL CELL RESEARCH
- IL-17 enhances the migration of B cells during asthma by inducing CXCL13 chemokine production in structural lung cells
- (2017) Roua Al-Kufaidy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways
- (2017) Jeffrey S. Smith et al. MOLECULAR PHARMACOLOGY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamic regulation of GDP binding to G proteins revealed by magnetic field-dependent NMR relaxation analyses
- (2017) Yuki Toyama et al. Nature Communications
- Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway
- (2017) Rachana Garg et al. Cell Reports
- Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection
- (2017) Federico Perdomo-Celis et al. Frontiers in Immunology
- Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer
- (2017) Xiaowei Chen et al. OncoImmunology
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells
- (2016) Y. Wang et al. CURRENT MOLECULAR MEDICINE
- Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL INVESTIGATION
- Id2 reinforces TH1 differentiation and inhibits E2A to repress TFH differentiation
- (2016) Laura A Shaw et al. NATURE IMMUNOLOGY
- CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles
- (2016) Yew Ann Leong et al. NATURE IMMUNOLOGY
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCL13 is a plasma biomarker of germinal center activity
- (2016) Colin Havenar-Daughton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
- (2015) C. Hsu et al. CLINICAL CANCER RESEARCH
- LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6
- (2015) Youn Soo Choi et al. NATURE IMMUNOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- TCF-1 at the Tfh and Th1 Divergence
- (2015) Yaping Chen et al. TRENDS IN IMMUNOLOGY
- Zebrafish as a disease model for studying human hepatocellular carcinoma
- (2015) Jeng-Wei Lu WORLD JOURNAL OF GASTROENTEROLOGY
- CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer
- (2015) Yixin Ding et al. Oncotarget
- p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
- (2015) Nikita A. Mitkin et al. Scientific Reports
- TCF1 Is Required for the T Follicular Helper Cell Response to Viral Infection
- (2015) Tuoqi Wu et al. Cell Reports
- Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
- (2015) Kavitha Gowrishankar et al. PLoS One
- Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma
- (2014) RAJESH SINGH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
- (2014) E. Sierra-Filardi et al. JOURNAL OF IMMUNOLOGY
- CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
- (2014) Zhenyu Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
- (2014) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
- (2014) C. Wang et al. Cancer Immunology Research
- CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
- (2013) Subir Biswas et al. BREAST CANCER RESEARCH AND TREATMENT
- CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
- (2013) Bridget Charbonneau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Specific Cytotoxic T Cells Are Crucial for Efficacy of Immunomodulatory Antibodies in Patients with Lung Cancer
- (2013) J. G. Aerts et al. CANCER RESEARCH
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5
- (2013) Christelle P El-Haibi et al. Molecular Cancer
- Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
- (2012) K. Franciszkiewicz et al. CANCER RESEARCH
- Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression
- (2012) Evangelia Razis et al. Clinical Breast Cancer
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Bcl6 and Maf Cooperate To Instruct Human Follicular Helper CD4 T Cell Differentiation
- (2012) M. A. Kroenke et al. JOURNAL OF IMMUNOLOGY
- The development and fate of follicular helper T cells defined by an IL-21 reporter mouse
- (2012) Katja Lüthje et al. NATURE IMMUNOLOGY
- CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor–bone microenvironment
- (2012) Y Sambandam et al. ONCOGENE
- The pros and cons of chemokines in tumor immunology
- (2012) Antonella Viola et al. TRENDS IN IMMUNOLOGY
- Early Th1 Cell Differentiation Is Marked by a Tfh Cell-like Transition
- (2011) Shingo Nakayamada et al. IMMUNITY
- Opposing Signals from the Bcl6 Transcription Factor and the Interleukin-2 Receptor Generate T Helper 1 Central and Effector Memory Cells
- (2011) Marion Pepper et al. IMMUNITY
- The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns
- (2011) Kenneth J. Oestreich et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors
- (2011) F. Del Grosso et al. MOLECULAR CANCER RESEARCH
- The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells
- (2011) Masaki Miyazaki et al. NATURE IMMUNOLOGY
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1
- (2010) Shoba Amarnath et al. PLOS BIOLOGY
- Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice
- (2009) Subramanya N.M. Pandruvada et al. INTERNATIONAL JOURNAL OF CANCER
- Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation
- (2009) R. J. Johnston et al. SCIENCE
- Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma
- (2008) W Vermi et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation